Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?

It has been about a month since the last earnings report for Denali Therapeutics Inc. (DNLI) . Shares have added about 15.6% in that time frame, outperforming the S&P 500. Denali Q1 Earnings Miss, Pipeline Progress in Focus The year-over-year narrower loss was due to a decline in operating expenses. Quarter in Detail Research and development expenses fell 17% to $107 million in the quarter. The decrease was mainly attributable to a decrease in ETV:IDS program external expenses year. As of Mar 31, 2024, cash ...